Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.

Dovc K, Piona C, Yeşiltepe Mutlu G, Bratina N, Jenko Bizjan B, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetes Care. 2019 Oct 1. pii: dc190895. doi: 10.2337/dc19-0895. [Epub ahead of print]

PMID:
31575640
2.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

3.

Decision Support Systems and Closed Loop.

Nimri R, Ochs AR, Pinsker JE, Phillip M, Dassau E.

Diabetes Technol Ther. 2019 Feb;21(S1):S42-S56. doi: 10.1089/dia.2019.2504. Review. No abstract available.

PMID:
30785322
4.

DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.

Biester T, Nir J, Remus K, Farfel A, Muller I, Biester S, Atlas E, Dovc K, Bratina N, Kordonouri O, Battelino T, Philip M, Danne T, Nimri R.

Diabetes Obes Metab. 2018 Nov 26. doi: 10.1111/dom.13585. [Epub ahead of print]

PMID:
30478937
5.

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians.

Nimri R, Dassau E, Segall T, Muller I, Bratina N, Kordonouri O, Bello R, Biester T, Dovc K, Tenenbaum A, Brener A, Šimunović M, Sakka SD, Nevo Shenker M, Passone CG, Rutigliano I, Tinti D, Bonura C, Caiulo S, Ruszala A, Piccini B, Giri D, Stein R, Rabbone I, Bruzzi P, Omladič JŠ, Steele C, Beccuti G, Yackobovitch-Gavan M, Battelino T, Danne T, Atlas E, Phillip M.

Diabetes Obes Metab. 2018 Oct;20(10):2458-2466. doi: 10.1111/dom.13408. Epub 2018 Jul 18.

PMID:
29885025
6.

Closing the Loop.

Nimri R, Audon P, Pinsker JE, Dassau E.

Diabetes Technol Ther. 2018 Feb;20(S1):S41-S54. doi: 10.1089/dia.2018.2504. Review. No abstract available.

PMID:
29437478
7.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

8.

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.

Dovc K, Macedoni M, Bratina N, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetologia. 2017 Nov;60(11):2157-2167. doi: 10.1007/s00125-017-4395-z. Epub 2017 Aug 24.

9.

Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.

Battelino T, Nimri R, Dovc K, Phillip M, Bratina N.

Diabetes Care. 2017 Jun;40(6):764-770. doi: 10.2337/dc16-2584. Epub 2017 Mar 28.

PMID:
28351897
10.

Closing the Loop.

Nimri R, Murray N, Ochs A, Pinsker JE, Dassau E.

Diabetes Technol Ther. 2017 Feb;19(S1):S27-S41. doi: 10.1089/dia.2017.2504. Review. No abstract available.

PMID:
28192023
11.

MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.

Nimri R, Bratina N, Kordonouri O, Avbelj Stefanija M, Fath M, Biester T, Muller I, Atlas E, Miller S, Fogel A, Phillip M, Danne T, Battelino T.

Diabetes Obes Metab. 2017 Apr;19(4):553-561. doi: 10.1111/dom.12852. Epub 2017 Jan 19.

PMID:
27981804
12.

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.

Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, DeVries JH, Doyle FJ 3rd, Griffen SC, Haidar A, Heinemann L, Hovorka R, Jones TW, Kollman C, Kovatchev B, Levy BL, Nimri R, O'Neal DN, Philip M, Renard E, Russell SJ, Weinzimer SA, Zisser H, Lum JW.

Diabetes Care. 2016 Jul;39(7):1175-9. doi: 10.2337/dc15-2716. Review.

13.

Multinational Home Use of Closed-Loop Control Is Safe and Effective.

Anderson SM, Raghinaru D, Pinsker JE, Boscari F, Renard E, Buckingham BA, Nimri R, Doyle FJ 3rd, Brown SA, Keith-Hynes P, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Farret A, Place J, Ly TT, Shanmugham S, Phillip M, Dassau E, Dasanayake IS, Kollman C, Lum JW, Beck RW, Kovatchev B; Control to Range Study Group.

Diabetes Care. 2016 Jul;39(7):1143-50. doi: 10.2337/dc15-2468. Epub 2016 Apr 13.

14.

Closing the Loop.

Nimri R, Yakoob H, Schoenberg B, Dassau E.

Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S29-42. doi: 10.1089/dia.2016.2504. Review. No abstract available.

PMID:
26836427
15.

Toward Automation of Insulin Delivery - Management Solutions for Type 1 Diabetes.

Nimri R, Phillip M.

Endocr Dev. 2016;30:1-13. doi: 10.1159/000439321. Epub 2015 Dec 10. Review.

PMID:
26682752
16.

Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).

Ziegler C, Liberman A, Nimri R, Muller I, Klemenčič S, Bratina N, Bläsig S, Remus K, Phillip M, Battelino T, Kordonouri O, Danne T, Lange K.

J Diabetes Res. 2015;2015:590308. doi: 10.1155/2015/590308. Epub 2015 Oct 25.

17.

A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly.

Oron T, Farfel A, Muller I, Miller S, Atlas E, Nimri R, Phillip M.

Diabetes Technol Ther. 2014 Nov;16(11):699-705. doi: 10.1089/dia.2014.0090. Epub 2014 Sep 11.

PMID:
25211216
18.

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

Chase HP, Doyle FJ 3rd, Zisser H, Renard E, Nimri R, Cobelli C, Buckingham BA, Maahs DM, Anderson S, Magni L, Lum J, Calhoun P, Kollman C, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):623-32. doi: 10.1089/dia.2014.0050. Epub 2014 Sep 4.

19.

MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.

Nimri R, Muller I, Atlas E, Miller S, Fogel A, Bratina N, Kordonouri O, Battelino T, Danne T, Phillip M.

Diabetes Care. 2014 Nov;37(11):3025-32. doi: 10.2337/dc14-0835. Epub 2014 Jul 30.

PMID:
25078901
20.

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

Zisser H, Renard E, Kovatchev B, Cobelli C, Avogaro A, Nimri R, Magni L, Buckingham BA, Chase HP, Doyle FJ 3rd, Lum J, Calhoun P, Kollman C, Dassau E, Farret A, Place J, Breton M, Anderson SM, Dalla Man C, Del Favero S, Bruttomesso D, Filippi A, Scotton R, Phillip M, Atlas E, Muller I, Miller S, Toffanin C, Raimondo DM, De Nicolao G, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):613-22. doi: 10.1089/dia.2014.0066. Epub 2014 Jul 8. Erratum in: Diabetes Technol Ther. 2015 Jan;17(1):68. Vistenin, Roberto [corrected to Visentin, Roberto].

21.

Artificial pancreas: fuzzy logic and control of glycemia.

Nimri R, Phillip M.

Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):251-6. doi: 10.1097/MED.0000000000000073. Review.

PMID:
24937038
22.

Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].

Busiah K, Drunat S, Vaivre-Douret L, Bonnefond A, Simon A, Flechtner I, Gérard B, Pouvreau N, Elie C, Nimri R, De Vries L, Tubiana-Rufi N, Metz C, Bertrand AM, Nivot-Adamiak S, de Kerdanet M, Stuckens C, Jennane F, Souchon PF, Le Tallec C, Désirée C, Pereira S, Dechaume A, Robert JJ, Phillip M, Scharfmann R, Czernichow P, Froguel P, Vaxillaire M, Polak M, Cavé H; French NDM study group.

Lancet Diabetes Endocrinol. 2013 Nov;1(3):199-207. doi: 10.1016/S2213-8587(13)70059-7. Epub 2013 Sep 6. Erratum in: Lancet Diabetes Endocrinol. 2013 Nov;1(3):e14.

PMID:
24622368
23.

Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.

Nimri R, Muller I, Atlas E, Miller S, Kordonouri O, Bratina N, Tsioli C, Stefanija MA, Danne T, Battelino T, Phillip M.

Pediatr Diabetes. 2014 Mar;15(2):91-9. doi: 10.1111/pedi.12071. Epub 2013 Aug 15.

PMID:
23944875
24.

The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.

Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T.

Pediatr Diabetes. 2013 May;14(3):159-67. doi: 10.1111/pedi.12025. Epub 2013 Feb 28.

PMID:
23448393
25.

Nocturnal glucose control with an artificial pancreas at a diabetes camp.

Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T.

N Engl J Med. 2013 Feb 28;368(9):824-33. doi: 10.1056/NEJMoa1206881.

26.

Metabolic control by insulin detemir in basal-bolus therapy: treat-to-target study in children and adolescents with type 1 diabetes.

Nimri R, Lebenthal Y, Shalitin S, Benzaquen H, Demol S, Phillip M.

Pediatr Diabetes. 2013 May;14(3):196-202. doi: 10.1111/pedi.12012. Epub 2013 Jan 4.

PMID:
23289822
27.

Clinical evaluation of a personalized artificial pancreas.

Dassau E, Zisser H, Harvey RA, Percival MW, Grosman B, Bevier W, Atlas E, Miller S, Nimri R, Jovanovic L, Doyle FJ 3rd.

Diabetes Care. 2013 Apr;36(4):801-9. doi: 10.2337/dc12-0948. Epub 2012 Nov 27.

28.

Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.

Nimri R, Atlas E, Ajzensztejn M, Miller S, Oron T, Phillip M.

Diabetes Technol Ther. 2012 Aug;14(8):728-35. doi: 10.1089/dia.2012.0004.

PMID:
22853723
29.

Androgen insensitivity syndrome: risk of malignancy and timing of surgery in a paediatric and adolescent population.

Kravarusic D, Seguier-Lipszyc E, Feigin E, Nimri R, Nagelberg N, Freud E.

Afr J Paediatr Surg. 2011 May-Aug;8(2):194-8. doi: 10.4103/0189-6725.86061.

30.

Automatic learning algorithm for the MD-logic artificial pancreas system.

Miller S, Nimri R, Atlas E, Grunberg EA, Phillip M.

Diabetes Technol Ther. 2011 Oct;13(10):983-90. doi: 10.1089/dia.2010.0216. Epub 2011 Jul 20.

PMID:
21774690
31.

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.

Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J.

Diabetes Care. 2011 Apr;34(4):795-800. doi: 10.2337/dc10-1989. Epub 2011 Feb 19.

32.

A novel loss-of-function mutation in GPR54/KISS1R leads to hypogonadotropic hypogonadism in a highly consanguineous family.

Nimri R, Lebenthal Y, Lazar L, Chevrier L, Phillip M, Bar M, Hernandez-Mora E, de Roux N, Gat-Yablonski G.

J Clin Endocrinol Metab. 2011 Mar;96(3):E536-45. doi: 10.1210/jc.2010-1676. Epub 2010 Dec 30.

PMID:
21193544
33.

Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.

Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M.

Diabet Med. 2010 Mar;27(3):339-47. doi: 10.1111/j.1464-5491.2009.02925.x.

PMID:
20536498
34.

MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes.

Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M.

Diabetes Care. 2010 May;33(5):1072-6. doi: 10.2337/dc09-1830. Epub 2010 Feb 11.

35.

Hypothyroidism in Netherton syndrome.

Garty BZ, Nimri R.

Pediatr Dermatol. 2008 Jan-Feb;25(1):134-5. doi: 10.1111/j.1525-1470.2007.00608.x. No abstract available.

PMID:
18304180
36.

Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.

Polak M, Dechaume A, Cavé H, Nimri R, Crosnier H, Sulmont V, de Kerdanet M, Scharfmann R, Lebenthal Y, Froguel P, Vaxillaire M; French ND (Neonatal Diabetes) Study Group.

Diabetes. 2008 Apr;57(4):1115-9. doi: 10.2337/db07-1358. Epub 2008 Jan 2.

37.

Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4alpha, GCK and TCF1 in patients with MODY in Israel.

Stern E, Strihan C, Potievsky O, Nimri R, Shalitin S, Cohen O, Shehadeh N, Weintrob N, Phillip M, Gat-Yablonski G.

J Pediatr Endocrinol Metab. 2007 Aug;20(8):909-21.

PMID:
17937063
38.

Children diagnosed with diabetes during infancy have unique clinical characteristics.

Nimri R, Phillip M, Shalitin S.

Horm Res. 2007;67(6):263-7. Epub 2006 Dec 14.

PMID:
17170528
39.

Bilateral diaphragm paralysis following cardiac surgery in children: 10-years' experience.

Dagan O, Nimri R, Katz Y, Birk E, Vidne B.

Intensive Care Med. 2006 Aug;32(8):1222-6. Epub 2006 Jun 2.

PMID:
16741697
40.

Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.

Nimri R, Weintrob N, Benzaquen H, Ofan R, Fayman G, Phillip M.

Pediatrics. 2006 Jun;117(6):2126-31.

PMID:
16740856
41.

Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.

Zung A, Glaser B, Nimri R, Zadik Z.

J Clin Endocrinol Metab. 2004 Nov;89(11):5504-7.

PMID:
15531505
42.

Kingella kingae occult bacteremia in a toddler.

Krause I, Nimri R.

Pediatr Infect Dis J. 1996 Jun;15(6):557-8. No abstract available.

PMID:
8783365

Supplemental Content

Support Center